LI, W. P. Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (doxetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2020, 2020, vol. 67, no. 6, s. 1409-1415.